Search

Displaying results 9171 - 9180 of 10000 in total
  1. Drug

    ISIS 14803

    go.drugbank.com/drugs/DB05803
    Investigational

    ISIS 14803 is a 20-unit antisense phosphorothioate oligodeoxynucleotide that binds to hepatitis C virus (HCV) RNA at the translation initiation region of the internal ribosome entry site (IRES) and inhibits

  2. Drug

    AV-412

    go.drugbank.com/drugs/DB06021
    Investigational

  3. Drug

    Apatorsen

    go.drugbank.com/drugs/DB06094
    Investigational

    Apatorsen is a second generation antisense drug which in preclinical experiments, inhibits production of Heat Shock Protein 27 (Hsp27) a cell survival protein found at elevated levels in many human cancers

  4. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  5. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  6. Drug

    Refametinib

    go.drugbank.com/drugs/DB06309
    Investigational

  7. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  8. Drug

    MLN2222

    go.drugbank.com/drugs/DB06503
    Experimental

    MLN2222 is a novel, proprietary recombinant protein that blocks both the C3 and C5 convertases, which are essential components of the complement activation pathway.

  9. Drug

    Lerdelimumab

    go.drugbank.com/drugs/DB06557
    Experimental

  10. Drug

    AM365

    go.drugbank.com/drugs/DB06564
    Experimental

    Detiviciclovir (AM365) is an antiviral nucleoside analogue.